Franklin Biotechnology Discv N Acc $

Performance History30/04/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv N Acc $
Fund101.247.739.5-28.110.1
+/-Cat6.23.6-4.10.9-1.1
+/-Idx-5.93.2-4.7-5.62.6
 
Key Stats
NAV
26/05/2017
 USD 25.16
Day Change -0.39%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0122613499
Fund Size (Mil)
30/04/2017
 USD 2516.29
Share Class Size (Mil)
30/04/2017
 USD 169.29
Max Initial Charge 3.00%
Ongoing Charge
27/01/2017
  2.59%
Investment Objective: Franklin Biotechnology Discv N Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns26/05/2017
YTD0.85
3 Years Annualised14.79
5 Years Annualised27.12
10 Years Annualised17.90
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
29/12/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv N Acc $30/04/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks92.850.0092.85
Bonds0.000.000.00
Cash6.040.006.04
Other1.110.001.11
Top 5 Regions%
United States96.70
United Kingdom0.94
Middle East0.89
Canada0.69
Eurozone0.62
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.26
Biogen IncHealthcareHealthcare6.26
Alexion Pharmaceuticals IncHealthcareHealthcare5.86
Incyte CorpHealthcareHealthcare5.63
Tesaro IncHealthcareHealthcare5.47
Franklin Biotechnology Discv N Acc $